ViroCell Biologics Retroviral & Lentiviral Vector CDMO
Contact Us
Leadership Team Scientific Advisory Board Board of Directors
Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing
Notes from the Inside Viral Vector Science Videos + Webinars Articles
In the News Press Releases Conferences
Careers
Team ViroCell Leadership Team Scientific Advisory Board Board of Directors What we do Overview Innovation Research Viral vector design & optimization Viral Vector Process Development GMP lentiviral & retroviral vector manufacturing Innovative thinking Notes from the Inside Viral Vector Science Videos + Webinars Articles
ViroCell Biologics Retroviral & Lentiviral Vector CDMO
News In the News Press Releases Conferences Manufacturing dreams Careers Contact Us
 

Notes from the inside

 
Rethinking Rare Disease: Why gene therapy must be built backwards to succeed
Rethinking Rare Disease: Why gene therapy must be built backwards to succeed
Florence BuchananAugust 28, 2025
Empowering Innovation with Purpose: Supporting not-for-profits advancing cell and gene therapy
Empowering Innovation with Purpose: Supporting not-for-profits advancing cell and gene therapy
Florence BuchananAugust 14, 2025
The Lentiviral Comeback: Why LVVs are poised to redefine in vivo gene therapy
The Lentiviral Comeback: Why LVVs are poised to redefine in vivo gene therapy
Florence BuchananAugust 7, 2025
 

Webinar

Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design
Sept 3, 2025

videos
 

If you’re looking for a lentiviral and retroviral vector CDMO, we’d love to connect

Get in touch
videosNewsroomCareersContact UsTerms of UsePrivacy Notice

London

 

ViroCell Holdings Limited (trading as ViroCell Biologics), registered in England and Wales, Company No. 16812976. Registered Office: 5 New Street Square, London EC4A 3TW ©2026 ViroCell Holdings Limited. All rights reserved.